Identification of Corynebacterium ulcerans and Erysipelothrix sp. in Malayan pangolins-a potential threat to public health?

Identification of Corynebacterium ulcerans and Erysipelothrix sp. in Malayan pangolins-a potential threat to public health?

Publication date: Sep 30, 2024

The discovery of severe acute respiratory syndrome-coronavirus-2-like and Middle East respiratory syndrome-coronavirus-like viruses in Malayan pangolins has raised concerns about their potential role in the spread of zoonotic diseases. Herein, we describe the isolation and whole-genome sequencing of potentially zoonotic two bacterial pathogens from diseased Malaysian pangolins (Manis javanica)-Corynebacterium ulcerans and Erysipelothrix sp. The newly identified species were designated as C. ulcerans P69 and Erysipelothrix sp. P66. C. ulcerans P69 exhibited 99. 2% whole-genome nucleotide identity to human bacterial isolate 4940, suggesting that it might have zoonotic potential. Notably, C. ulcerans P69 lacked the diphtheria toxin (tox) gene that is widely used in vaccines to protect humans from corynebacterial infection, which suggests that the current vaccine may be of limited efficacy against this pangolin strain. C. ulcerans P69 also contains other known virulence-associated genes such as pld and exhibits resistance to several antibiotics (erythromycin, clindamycin, penicillin G, gentamicin, tetracycline), which may affect its effective control. Erysipelothrix sp. P66 was closely related to Erysipelothrix sp. strain 2-related strains, exhibiting 98. 8% whole-genome nucleotide identity. This bacterium is lethal in mice, and two commercial vaccines failed to protect its challenge, such that it could potentially pose a threat to the swine industry. Overall, this study highlights that, in addition to viruses, pangolins harbor bacteria that may pose a potential threat to humans and domestic animals, and which merit attention. This study firstly reports the presence of two potentially zoonotic bacteria, Corynebacterium ulcerans and Erysipelothrix sp. , in diseased Malaysian pangolins collected in 2019. The pangolin C. ulcerans is lethal in mice and resists many antibiotics. It clustered with a lethal human strain but lacked the diphtheria toxin gene. Diphtheria toxin is widely used as a vaccine around the world to protect humans from the infection of corynebacteria. The lack of the tox gene suggests that the current vaccine may be of limited efficacy against this pangolin strain. The pangolin Erysipelothrix sp. is the sister clade of Erysipelothrix rhusiopathiae. It is lethal in mice, and two commercial vaccines failed to protect the mice against challenge with the pangolin Erysipelothrix sp. , such that this strain could potentially pose a threat to the swine industry. These findings emphasize the potential threat of pangolin bacteria.

Open Access PDF

Concepts Keywords
Coronavirus Corynebacterium ulcerans
Corynebacteria Erysipelothrix sp.
Lethal pangolin
Mice zoonosis
Pangolin

Semantics

Type Source Name
disease MESH severe acute respiratory syndrome
disease MESH Middle East respiratory syndrome
disease IDO role
disease MESH zoonotic diseases
disease MESH infection
disease IDO virulence
drug DRUGBANK Erythromycin
drug DRUGBANK Clindamycin
drug DRUGBANK Benzylpenicillin
drug DRUGBANK Gentamicin
drug DRUGBANK Tetracycline
disease IDO bacteria
drug DRUGBANK (S)-Des-Me-Ampa
disease IDO zoonosis
disease MESH death
drug DRUGBANK Coenzyme M
disease MESH COVID 19
disease MESH parainfluenza
disease MESH Bacterial infections
disease MESH diphtheria
disease IDO commensal
disease IDO pathogen
disease MESH erysipelas
disease MESH swine erysipelas
disease MESH erysipeloid
disease MESH viral infections
disease IDO susceptibility
disease IDO protein
pathway REACTOME Translation
pathway REACTOME Metabolism
disease IDO replication
disease IDO host
disease IDO country
disease IDO virulence factor
drug DRUGBANK Amino acids
drug DRUGBANK Proline
drug DRUGBANK Methyl isocyanate
drug DRUGBANK Vancomycin
disease MESH weight loss
drug DRUGBANK Methyprylon
disease MESH necrosis
disease MESH Atrophy
disease IDO blood
disease MESH bleeding
disease MESH depression
disease MESH anorexia
drug DRUGBANK Tilmicosin
drug DRUGBANK Oxacillin
drug DRUGBANK Cefoxitin
drug DRUGBANK Ciprofloxacin
disease IDO exotoxin
disease MESH pneumonia
disease IDO antibiotic resistance
disease MESH morbidity
drug DRUGBANK Ethanol
drug DRUGBANK Water
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Guanosine
drug DRUGBANK Carboxyamidotriazole
disease IDO cell
disease MESH viral zoonotic infections
drug DRUGBANK Corynebacterium diphtheriae
disease IDO emerging pathogen
disease MESH infectious diseases
disease MESH endocarditis
disease MESH osteomyelitis
disease MESH parvovirus infections
disease MESH intestinal perforation
disease MESH secondary peritonitis
disease MESH ulcer
drug DRUGBANK Ribostamycin
drug DRUGBANK Ferrous sulfate anhydrous
disease IDO infectivity
drug DRUGBANK Vorinostat

Original Article

(Visited 1 times, 1 visits today)